| The potential and controversy of targeting STAT family members in cancer Y Verhoeven, S Tilborghs, J Jacobs, J De Waele, D Quatannens, ... Seminars in cancer biology 60, 41-56, 2020 | 345 | 2020 |
| The role of nuclear factor-kappa B signaling in human cervical cancer S Tilborghs, J Corthouts, Y Verhoeven, D Arias, C Rolfo, XB Trinh, ... Critical reviews in oncology/hematology 120, 141-150, 2017 | 272 | 2017 |
| RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment PA Van Dam, Y Verhoeven, XB Trinh, A Wouters, F Lardon, H Prenen, ... Critical reviews in oncology/hematology 133, 85-91, 2019 | 66 | 2019 |
| Cancer-associated fibroblasts as a common orchestrator of therapy resistance in lung and pancreatic cancer A Domen, D Quatannens, S Zanivan, C Deben, J Van Audenaerde, ... Cancers 13 (5), 987, 2021 | 57 | 2021 |
| Triple‐negative breast cancer—role of immunology: a systemic review G Oner, S Altintas, Z Canturk, W Tjalma, Y Verhoeven, C Van Berckelaer, ... The Breast Journal 26 (5), 995-999, 2020 | 51 | 2020 |
| Targeting hedgehog signaling in pancreatic ductal adenocarcinoma D Quatannens, Y Verhoeven, P Van Dam, F Lardon, H Prenen, G Roeyen, ... Pharmacology & Therapeutics 236, 108107, 2022 | 38 | 2022 |
| RANK-RANKL signaling in cancer of the uterine cervix: a review PA Van Dam, Y Verhoeven, J Jacobs, A Wouters, W Tjalma, F Lardon, ... International journal of molecular sciences 20 (9), 2183, 2019 | 31 | 2019 |
| The immunologic aspects in hormone receptor positive breast cancer G Oner, S Altintas, Z Canturk, W Tjalma, C Van Berckelaer, G Broeckx, ... Cancer Treatment and Research Communications 25, 100207, 2020 | 17 | 2020 |
| Targeting the PD-1 axis with pembrolizumab for recurrent or metastatic cancer of the uterine cervix: a brief update Y Verhoeven, D Quatannens, XB Trinh, A Wouters, ELJ Smits, F Lardon, ... International journal of molecular sciences 22 (4), 1807, 2021 | 13 | 2021 |
| Bone metastases in the era of targeted treatments: insights from molecular biology J Dewulf, C Vangestel, Y Verhoeven, P Van Dam, F Elvas, ... The quarterly journal of nuclear medecine and molecular imaging.-Torino …, 2019 | 10 | 2019 |
| The non-bone-related role of RANK/RANKL signaling in cancer PA Van Dam, Y Verhoeven, XB Trinh Tumor microenvironment: molecular players–part B, 53-62, 2020 | 8 | 2020 |
| Immuno-PET molecular imaging of RANKL in cancer J Dewulf, C Vangestel, Y Verhoeven, J De Waele, K Zwaenepoel, ... Cancers 13 (9), 2166, 2021 | 3 | 2021 |
| Uncovering the immune-modulating role of anti-RANKL therapy for cervical cancer: Preliminary results. P Van Dam, Y Verhoeven, J De Waele, J Jacobs, PJ Van Dam, M Kockx, ... Journal of Clinical Oncology 38 (15_suppl), e18028-e18028, 2020 | | 2020 |
Sam TilborghsPhD researcher, University of AntwerpVerifisert e-postadresse på student.uantwerpen.be
